<?xml version="1.0" encoding="UTF-8"?>
<p>Participants in all groups will receive conventional Western medical treatments as recommended by the Guidelines of Chinese Society of Clinical Oncology: Prevention and treatment of nausea and vomiting caused by antitumor therapies,
 <sup>[
  <xref rid="R21" ref-type="bibr">21</xref>]
 </sup> including 5-HT3 receptor antagonist, NK-1 receptor antagonist, dexamethasone, and so on. In addition to conventional treatment, patients in Group A and Group B will receive AA or EA regimens, alternatively.
</p>
